Table 3.
Dose–response relationship of ODP with AST, ALT, and ALP in mice.
| Group/Index | AST(U/L) | ALT(U/L) | ALP(U/L) |
|---|---|---|---|
| NC | 38.46 ± 6.65 | 71.88 ± 6.72 | 5.67 ± 1.00 |
| MC | 57.7 ± 3.38 ** | 101.29 ± 12.25 ** | 9.09 ± 1.54 ** |
| YC | 41.52 ± 5.46 ## | 76.59 ± 8.11 # | 6.52 ± 1.09 ## |
| ODP1 (50 mg/kg) | 46.26 ± 5.82 ## | 86.23 ± 6.03 | 7.63 ± 0.91 # |
| ODP2 (100 mg/kg) | 46.93 ± 9.31 ## | 85.90 ± 10.94 | 7.64 ± 0.88 # |
| ODP3 (200 mg/kg) | 43.06 ± 4.31 ## | 71.55 ± 5.95 ## | 6.96 ± 0.50 ## |
| ODP4 (400 mg/kg) | 44.10 ± 5.02 ## | 71.85 ± 8.24 ## | 6.60 ± 0.51 ## |
| ODP5 (600 mg/kg) | 50.41 ± 2.18 ## | 81.34 ± 15.41 | 6.85 ± 1.31 ## |
NC: normal control group, MC: CdCl2-treated group. YC: positive-treated group. ODP1–5: ODP (50, 100, 200, 400, 600 mg/kg)-treated group. * Compared with normal control group (NC group), ** p < 0.01; # compared with model control group (MC group), # p < 0.05, ## p < 0.01.